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Keratitis-ichthyosis-deafness (KID syndrome) is a syndromes ichthyoses that is 
clinically and genetically heterogeneous requiring early and long-term 
multidisciplinary monitoring of affected individuals. A review of the clinical, 
etiopathogenic and therapeutic aspects is presented of this rare congenital 
ectodermal disorder. 




















The ichythyoses consist of clinically and genetically heterogeneous Mendelian 
disorders of cornification. Inherited ichthyoses are subdivided into non-syndromic 
ichthyoses with phenotypes that are restricted to the skin and syndromic ichthyoses 
with defects in skin and other organs (Yoneda, 2016). Keratitis-ichthyosis-deafness 
(KID syndrome, OMIM 148210 and 242150) (Cheung et al., 2019; Dalamón et al., 
2016; Lee et al., 2019; Ogawa et al., 2014; Serrano-Ahumada et al., 2018; Wonkam 
et al., 2013; Yoneda, 2016), was initially described by Burns in 1915 (Burns, 1915; 
Cheung et al., 2019; Yoneda, 2016), and the acronym is proposed by Skinner et al., 
in 1981(Cheung et al., 2019; Skinner et al., 1981; Wonkam et al., 2013; Yoneda, 
2016). KID syndrome is a rare congenital disorder characterized by the association 
of the classic triad of chronic vascularizing keratitis, ichthyosiform erythroderma and 
moderate to profound bilateral prelingual sensorineural hearing loss (Abdollahi et al., 
2007; Cheung et al., 2019; Dalamón et al., 2016; Lee et al., 2019; Ogawa et al., 
2014; Patel et al., 2015; Sanchez et al., 2013; Serrano-Ahumada et al., 2018; Taki 
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et al., 2018; Wang X, et al., 2018; Wonkam et al., 2013; Yoneda, 2016), which often 
impacts speech (Patel et al., 2015). 
Clinical Features 
The skin findings are typically noted soon after birth as generalized scaling and 
extensive erythrokeratodermic, follicular hyperkeratoses, psoriasiform or verrucous 
plaques with scarring progressive alopecia (Cheung et al., 2019; Dalamón et al., 
2016; Lee et al., 2019; Patel et al., 2015; Yoneda, 2016), a typical reticulated pattern 
that is often defined as leather-like (Dalamón et al., 2016), palmoplantar 
keratoderma often described as reticulated or pitted, onychodystrophy, and due to 
the extensive skin involvement there is an increased risk of chronic, opportunistic 
cutaneous infection (bacterial or fungal) and in severe cases septicemia (Abdollahi 
et al., 2007; Cheung et al., 2019; Dalamón et al., 2016; Lee et al., 2019; Patel et al., 
2015; Taki et al., 2018). Furthermore, some patients develop thick perioral rugae 
and an aged appearance of the face (Figure 1) (Abdollahi et al., 2007), angular 
cheilitis and dental abnormalities (Cheung et al., 2019; Patel et al., 2015). Patients 
present an increased susceptibility of developing both benign and malignant 
cutaneous tumors, such as trichilemmoma and squamous cell carcinoma of mucous 
membranes in at least 12% of patients (Dalamón et al., 2016; Lee et al., 2019; Patel 
et al., 2015; Serrano-Ahumada et al., 2018; Taki et al., 2018), apparently due to p53 
loss in the lesions (Dalamón et al., 2016). The development has also been described 
spinocellular carcinoma from dermal or lingual lesions (Yoneda, 2016). These 
complications can have a significant impact on life expectancy (Lee et al., 2019). 
The ocular manifestations usually are progressive and develop during infancy 
(Abdollahi et al., 2007). There is significant corneal involvement with corneal 
epithelial defects, severe punctate keratitis (Abdollahi et al., 2007), progressive 
neovascularization (Cheung et al., 2019; Dalamón et al., 2016; Lee et al., 2019; 
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Serrano-Ahumada et al., 2018), which is bilateral but asymmetrical, (over 80% of 
cases) (Abdollahi et al., 2007), and recurring corneal erosions (Abdollahi et al., 2007; 
Cheung et al., 2019). There are disturbances of the tear film due to meibomitis and 
severe dry eye syndrome (Abdollahi et al., 2007). Ultimately pannus formation, 
corneal leukoma and limbal stem cell deficiency impact significantly on visual 
function. Other reported ocular manifestations include recurrent conjunctivitis, 
hypotrichosis of the eyebrows and lashes, and atrophy of secretory glands (Cheung 
et al., 2019). In one case ocular surface squamous neoplasia was reported (Serrano-
Ahumada et al., 2018). Ultimately pannus formation, corneal leukoma and limbal 
stem cell deficiency impact significantly on visual function (Dalamón et al., 2016). 
Etiopathogeny 
This hereditary cornification disorder is of unknown prevalence, and to date, 
approximately 100 cases of KID syndrome have been reported in the literature 
(Dalamón et al., 2016; Patel et al., 2015; Serrano-Ahumada et al., 2018; Wang X, et 
al., 2018; Wonkam et al., 2013). Inheritance is usually sporadic, but some familial 
forms have been reported with autosomal dominant and recessive transmission 
pattern (Abdollahi et al., 2007; Dalamón et al., 2016; Lee et al., 2019; Serrano-
Ahumada et al., 2018; Wang X, et al., 2018; Wonkam et al., 2013; Yoneda, 2016). 
KID syndrome is genetically heterogeneous and in the most cases are caused by 
heterozygous germline missense mutation in GJB2 gene (Cheung et al., 2019; 
Dalamón et al., 2016; Lee et al., 2019; Ogawa et al., 2014; Patel et al., 2015; 
Serrano-Ahumada et al., 2018; Wonkam et al., 2013; Yoneda, 2016), which encode 
the closely related gap junction β-2 protein (connexins 26) (Lee et al., 2019; Serrano-
Ahumada et al., 2018; Yoneda, 2016;). Additionally, two heterozygous non-
synonymous mutations p.Asp50Asn in GJB2 and p.Glu162Asp in TTC9 gene were 
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identified in two affected family members proposing new etiological cause (Wang X, 
et al., 2018). 
Connexins are integral membrane proteins forming gap junction channels for 
diffusional exchange of ions and other metabolites between cells (Serrano-Ahumada 
et al., 2018), and play part in a variety of biological functions that allow for intercellular 
communication between epithelial cells, cell growth and development (Cheung et 
al., 2019; Dalamón et al., 2016; Patel et al., 2015), and an expressed in keratinocytes 
and in support cells of the inner ear (Sanchez et al., 2013). 
Connexins present a common structure consisting of four transmembrane domains, 
linked by one cytoplasmic, and two extracellular loops (namely, EC1, and EC2, 
respectively), with both cytoplasmic N-terminal and C-terminal (Dalamón et al., 2016; 
Wonkam et al., 2013). The membrane spanning and the extracellular domains are 
highly conserved and the main differences between connexin are found in their C-
terminal tails. In the case of KID syndrome, all pathogenic mutations were described 
clustering in regions coding for the first extracellular domain and the N-terminal of 
connexin 26, implying common functional defects (Dalamón et al., 2016). 
Mutations in GJB2 gene were identified in several autosomal recessive non-
syndromic sensorineural deafness pedigrees (Dalamón et al., 2016; Sanchez et al., 
2014), and represent one of the most common causes of inherited deafness. More 
than 100 mutations have been identified and produce loss of function as a result of 
premature stop codons, deletions, insertions and frameshifts (Taki et al., 2018). The 
resultant loss of channel function produce the alteration of cochlear intercellular 
communication (Dalamón et al., 2016). However, mutations at 18 positions in 
connexin 26 have been identified in several syndromic deafness with varying 
phenotypes that alter epidermal differentiation, such as KID syndrome, palmoplantar 
keratoderma with deafness, Bart-Pumphrey syndrome and Vohwinkel syndrome. 
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Genetically, all of these disorders result from mutations in GJB2 gene, but the nature 
of each disease depends on the particular mutation detected (Dalamón et al., 2016; 
Sanchez et al., 2013; Sanchez et al., 2014). In contrast to non-syndromic deafness, 
syndromic deafness is characteristically cause by missense mutations of single 
residues, and behave in an autosomal dominant manner (Patel et al., 2015; Sanchez 
et al., 2014). 
To date, 12 missense GJB2 mutations have been reported to KID syndrome, and 
c.148G>A (p.Asp50Asn), is the most common; it has been reported in patients 
worldwide from different ethnic groups. This mutation is located in the first 
extracellular loop domain, E1, and thus, it has been suggested that Asp50Asn could 
alter gap junctions channel gating and/or affect hemichannel interactions (Dalamón 
et al., 2016; Lee et al., 2019; Sanchez et al., 2013). In addition to this recurrent 
mutation, others GJB2 mutations have been described in KID patients, such as 
p.Gly11Arg, p.Gly12Arg, p.Asn14Tyr, p.Ser17Phe, p.Ala40Val, p.Gly45Glu, 
p.Asp50Tyr and p.Gly54Glu (Dalamón et al., 2016). At least 10 out of the 12 
identified mutations, including c.148G>A (p.Asp50Asn), have been associated with 
aberrant hemichannel behavior, resulting in elevated membrane currents, enhanced 
permeability to small-molecule tracers, and/or enhanced ATP release in response to 
a specific stimuli (Lee et al., 2019). The mutations p.Gly45Glu and p. Ala88Val are 
associated with uniform early lethality so early genotyping of KID syndrome births 
will inform prognostic discussion (Lilly et al., 2019). 
The mutation c.148G>A (p.Asp50Asn) is also supported by the crystal structure of 
the connexins 26 gap junctions channel. These properties include a substantially 
reduced unitary conductance, increased open-state outward rectification, and 
strongly shifted voltage-dependent activation. Application of using the substituted 
Cys accessibility method confirmed this mutation as a pore-lining residue in connexin 
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26 hemichannels. Interestingly, the connexin 26 crystal structure suggests that 
p.Asp50Asn not only lines the pore, but also participates in inter-subunit interactions 
(Sanchez et al., 2013). In the epidermis, gap junctions appear to play a role in the 
coordination of keratinocyte growth and differentiation, whereas in the sensory 
epithelia of the inner ear they mainly regulate potassium recycling during auditory 
transduction. Several observations suggest that changes in the proliferation and 
differentiation pathway of keratinocytes correspond with a switch of the pattern of 
connexin expression in skin (Dalamón et al., 2016). 
KID syndrome autosomal recessive 
This entity is clinically characterized by ichthyosiform erythroderma, profound 
sensorineural deafness, vascularizing keratitis, developmental delay and failure to 
thrive.  There  are also reports of other ocular, dental, hepatic and metabolic defects  
(Alsaif et al., 2019; Boyden et al., 2019; Cremers et al., 1977; Desmons et al., 1971; 
Jurecka et al., 1985; Wilson et al., 1991).  
This subtype is caused by homozygous mutation in the AP1B1 gene at chromosomal 
region 22q12.2, as p.Glu14Argfs*5, and a deletion of 75 kb that removes the 
tentative promoter as well as the first two exons of AP1B1 gene, so it is predicted to 
be a null at the protein level (Alsaif et al., 2019) and other homozygous mutation as 
p.Glu792* (Boyden et al., 2019), or compound heterozygous in a male patient as 
p.Cys144Arg inherited from his unaffected mother and p.Leu779Serfs*26 inherited 
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The differential diagnosis, are shown in the Table 1 (Elsayed et al., 2011; Yoneda, 
2016). Hystrix-like ichthyosis with deafness syndrome (OMIM 602540) was initially 
considered a differ entity from the KID syndrome, however, the phenotypes are 
similar, and both present cancer predisposition with an increased incidence of 
squamous cell carcinoma. Subsequently, these entities were associated with an 
identical connexin 26 missense mutation (van Geel et al., 2002). This entity was not 
included in the classification of inherited ichthyoses, results of the first ichthyosis 
consensus conference (Oji et al., 2010) 
Examination and treatment 
There is an unmet need for targeted treatment of KID syndrome (Lee et al., 2019). 
Management is challenging for dermatologists as conventional treatments often lack 
efficacy and currently, there are no therapeutic guidelines for pediatric patients (Patel 
et al., 2015). Cutaneous treatment is limited to symptomatic management, including 
retinoid therapy, to attempt to improve the skin barrier, the application of keratolytic 
drugs and antifungal and antibacterial agents for the risk of infection (Yoneda, 2016; 
Lee et al., 2019).  
Keratitis, photophobia and low vision appear during childhood. Bilateral corneal 
pannus and neovascularisation is observed (Yoneda, 2016). Medical and surgical 
ocular interventions have demonstrated limited success in KID syndrome. Therapies 
have included artificial tears, corticosteroids, cyclosporine A, antibiotics (Cheung et 
al., 2019), subconjunctival bevacizumab in early stages could prevent corneal 
neovascularization (Caye et al., 2010; Cheung et al., 2019), penetrating 
keratoplasty, superficial keratectomy, removal of corneal pannus, corneal grafts, 
ocular surface stem cell transplantation, and keratoprosthesis implantation (Cheung 
et al., 2019). 
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Audiography is required to investigate the presence or absence of hearing disorder. 
For this control, hearing aids and cochlear implants are used. If malignant tumors of 
the skin develop, surgery should be performed (Yoneda, 2016). 
The urgent ophthalmologic and otolaryngologic measures and simple topical 
therapies may improve skin condition precluding the possible risk of systemic 
therapy (Abdollahi et al., 2007). Recent work has shown that mefloquine, an FDA-
approved anti-malarial drug, potently suppresses aberrant hemichannels in primary 
keratinocytes from a transgenic mouse model with heterozygous p.G45E mutation 
in GJB2. Very recently, the monoclonal antibody abEC1.1 was developed, which 
specifically suppressed hemichannels formed by connexins 26-wildtype, p.Gly45Glu 
or p.Asp50Asn mutants. However, it is unclear whether those strategies can 
discriminate mutant GJB2 allele from the wildtype. This concern is particularly 
important given the context that most KID syndrome mutants exert dominant effects 
on co-expressed wildtype connexins. In the last decade, allele-specific small 
interference RNA (AS-siRNA) technology has shown strong therapeutic potential in 
treatment of dominant genetic disorders and brought clinical (Lee et al., 2019). 
Although the general prognosis of KID syndrome appears to be favorable (Caye et 
al., 2010; Yoneda, 2016), but exanthema may persist over the lifetime (Yoneda, 
2016), early and long-term multidisciplinary monitoring of affected individuals is 
necessary (Caye et al., 2010). Attention should be paid to increased susceptibility to 
infections and increased risk of developing malignant tumors (Caye et al., 2010; 
Yoneda, 2016), particularly squamous cell carcinoma.  
Conclusions 
KID syndrome is a rare syndromic ichthyoses which is clinically and genetically 
heterogeneous but characterized by the association of the classic triad of chronic 
vascularizing keratitis, ichthyosiform erythroderma and sensorineural hearing loss. 
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Inheritance is usually sporadic, but some familial forms have been reported with 
autosomal dominant and recessive transmission pattern. Most cases are caused by 
heterozygous germline missense mutation in GJB2 gene that encode the connexins 
26, identified in several autosomal recessive non-syndromic sensorineural deafness 
as the most common causes. Mutations at 18 positions in the GJB2 gene have been 
identified in several syndromic deafness with varying phenotypes as KID syndrome, 
among others. Early and long-term multidisciplinary monitoring of affected 
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Table 1. Differential diagnosis of KID syndrome.
Entity OMIM Gene Location Inheritance Characteristic 
Ichthyosis hystrix Curth-Macklin 146590 KRT1 12q13.13 AD Intermediate filaments of keratin 
surrounding a nucleus like a shell are 
detected on electron microscopy




AD, AR Not cause keratitis
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